Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The sourcing situation for self-administered BPC-157 is genuinely problematic
Is the combination of BPC-157 and GLP-1 medication FDA-approved
A retrospective follow-up found that 87% of the participants receiving BPC-157 injections had significant relief of their knee pain that lasted for at least 6 months to a year (length of the follow-up).[ref] A clinical trial in rats found that taking BPC-157 orally in water significantly helped mytendonitis injuries after surgery
The cancer concern around BPC-157 is theoretical, based on its angiogenic properties
If you are managing muscle spasticity or have questions about medications affecting the nervous system, consulting a healthcare professional is essential
